Clinical Trials

NCT06046729 | ACTIVE_NOT_RECRUITING | PHASE2

352 participants

A Study of Eltrekibart (LY3041658) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-04

Start Date:

2023-10-23

Completion:

2025-09-30

Conditions

• Hidradenitis Suppurativa

Interventions

• DRUG

No Results Yet

NCT06044337 | ENROLLING_BY_INVITATION | PHASE3

306 participants

A Long-Term Extension Study to Learn More About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-04

Start Date:

2023-10-03

Completion:

2029-06-26

Conditions

• Subacute Cutaneous Lupus Erythematosus
• Chronic Cutaneous Lupus Erythematosus

Interventions

• DRUG

No Results Yet

NCT06011629 | COMPLETED | PHASE4

457 participants

Aquacel Hypersensitivity Dressing in TJAs

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-04

Start Date:

2023-06-18

Completion:

2024-11-01

Conditions

• Contact Allergic Dermatitis
• Adverse Skin Reaction

Interventions

• DEVICE

Results Available

NCT05999877 | ACTIVE_NOT_RECRUITING

192 participants

PICAROS - Acalabrutinib RWE on 1L CLL in Spain

Study Type:

OBSERVATIONAL

Last Updated:

2026-08-04

Start Date:

2023-07-11

Completion:

2029-03-31

Conditions

• Chronic Lymphocytic Leukemia

No Results Yet

NCT05995236 | TERMINATED

35 participants

Prostate-Specific Membrane Antigen (PSMA) Radionuclide Therapy

Study Type:

OBSERVATIONAL

Last Updated:

2026-08-04

Start Date:

2023-08-03

Completion:

2026-07-09

Conditions

• Prostate Cancer

Interventions

• DRUG

No Results Yet

NCT05990738 | ACTIVE_NOT_RECRUITING | PHASE1

69 participants

DAREON™-9: A Study to Test How Well Different Doses of BI 764532 Are Tolerated by People With Small Cell Lung Cancer When Taken Together With a Single Agent Chemotherapy

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-04

Start Date:

2024-02-14

Completion:

2027-03-30

Conditions

• Small Cell Lung Carcinoma (SCLC)

Interventions

• DRUG

No Results Yet

NCT05981118 | ENROLLING_BY_INVITATION | PHASE2/PHASE3

40 participants

Comparison of Post-Inflammatory Pigment Alteration After Psoriasis Treatment (PIPA - Dermavant)

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-04

Start Date:

2024-07-15

Completion:

2027-01-31

Conditions

• ICD10 Code L40.9 for Psoriasis

Interventions

• DRUG

No Results Yet

NCT05972850 | COMPLETED | NA

28 participants

Vivo Heart: Home-Based Virtual Exercise Program for Older Adults With Cardiovascular Disease

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-04

Start Date:

2024-03-19

Completion:

2025-05-16

Conditions

• Cardiovascular Disease

Interventions

• BEHAVIORAL

Results Available

NCT05968326 | RECRUITING | PHASE2

260 participants

A Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRINOX Versus mFOLFIRINOX Alone in Participants With Resected PDAC

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-04

Start Date:

2023-10-18

Completion:

2031-01-01

Conditions

• Adenocarcinoma, Pancreatic Ductal

Interventions

• DRUG

No Results Yet

NCT05925634 | ACTIVE_NOT_RECRUITING | NA

320 participants

Improving Cardiac Rehabilitation Exercise Using Target Heart Rate Trial

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-04

Start Date:

2023-08-10

Completion:

2026-10-24

Conditions

• Myocardial Infarction
• Coronary Artery Bypass
• Percutaneous Coronary Intervention
• Heart Failure
• Cardiac Valve Surgery

Interventions

• BEHAVIORAL

No Results Yet

NCT05916404 | COMPLETED | NA

42 participants

Effects of Upper Extremity Aerobic Exercise Training in Patients With Interstitial Lung Disease

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-04

Start Date:

2023-07-03

Completion:

2025-05-01

Conditions

• Interstitial Lung Disease

Interventions

• OTHER

No Results Yet

NCT05910021 | COMPLETED

35 participants

Early Safety of Resection Rectopexy and Sacrocolpopexy

Study Type:

OBSERVATIONAL

Last Updated:

2026-08-04

Start Date:

2020-02-01

Completion:

2024-03-31

Conditions

• Constipation by Outlet Obstruction
• Pelvic Organ Prolapse
• Urinary Incontinence

No Results Yet

NCT05906537 | COMPLETED | PHASE1

38 participants

SKB410 for Injection in Solid Tumors

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-04

Start Date:

2023-07-06

Completion:

2026-03-31

Conditions

• Advanced Solid Tumors

Interventions

• DRUG

No Results Yet

NCT05890183 | RECRUITING | NA

100 participants

Improving Cognition Through Telehealth Aerobic Exercise and Cognitive Training After a First Schizophrenia Episode

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-04

Start Date:

2023-05-23

Completion:

2028-05-31

Conditions

• Schizophrenia
• Schizophreniform Disorder
• Schizoaffective Disorder

Interventions

• BEHAVIORAL

No Results Yet

NCT05887713 | ACTIVE_NOT_RECRUITING | NA

200 participants

Novel Mental Health Therapies to Improve Military Readiness

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-04

Start Date:

2024-01-01

Completion:

2026-12-31

Conditions

• Anxiety
• Alpha Stim
• Cranial Electrotherapy Stimulation
• Cognitive Behavioral Therapy
• Heart Rate Variability

Interventions

• DEVICE

No Results Yet

NCT05879978 | ACTIVE_NOT_RECRUITING | PHASE1

45 participants

A Study to Test How Well Different Doses of Obrixtamig (BI 764532) in Combination With Ezabenlimab Are Tolerated by People With Small Cell Lung Cancer and Other Neuroendocrine Tumours That Are Positive for DLL3

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-04

Start Date:

2023-06-27

Completion:

2025-06-11

Conditions

• Small Cell Lung Carcinoma (SCLC)
• Neuroendocrine Neoplasms

Interventions

• DRUG

No Results Yet

NCT05879926 | RECRUITING | PHASE3

3960 participants

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-04

Start Date:

2023-10-18

Completion:

2032-01-31

Conditions

• Breast Cancer

Interventions

• DRUG

No Results Yet

NCT05875740 | RECRUITING

80 participants

Correlation of Memory CD8+ T Cells With Sepsis Severity and Mortality: a Single-center, Unblinded, Prospective, Non-interventional, Observational Study

Study Type:

OBSERVATIONAL

Last Updated:

2026-08-04

Start Date:

2023-09-06

Completion:

2026-08-31

Conditions

• Sepsis
• Inflammatory Response

No Results Yet

NCT05874843 | RECRUITING | NA

125 participants

Validation of Point-of-care Thromboelastography (TEG 6s) in Pediatric Patients

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-04

Start Date:

2023-09-11

Completion:

2026-12-31

Conditions

• Coagulopathy

Interventions

• DIAGNOSTIC_TEST

No Results Yet

NCT05863195 | RECRUITING | PHASE3

408 participants

Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-04

Start Date:

2023-10-19

Completion:

2029-06-30

Conditions

• Metastatic Colorectal Carcinoma
• Metastatic Malignant Neoplasm in the Liver
• Stage IV Colorectal Cancer AJCC v8
• Unresectable Colorectal Carcinoma

Interventions

• BIOLOGICAL
• PROCEDURE
• DRUG

No Results Yet

NCT05861986 | RECRUITING | PHASE4

28 participants

A Study Evaluating the Effectiveness and Safety of Risdiplam Administered as an Early Intervention in Pediatric Participants With Spinal Muscular Atrophy After Gene Therapy

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-04

Start Date:

2024-05-30

Completion:

2028-03-31

Conditions

• Muscular Atrophy, Spinal

Interventions

• DRUG

No Results Yet

NCT05846230 | ACTIVE_NOT_RECRUITING | PHASE2

268 participants

Clairleafᵀᴹ: A Study to Test Long-term Treatment With BI 1291583 in People With Bronchiectasis Who Took Part in a Previous Study With This Medicine

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-04

Start Date:

2023-09-08

Completion:

2027-03-31

Conditions

• Bronchiectasis

Interventions

• DRUG

No Results Yet

NCT05816889 | COMPLETED

56 participants

Investigation of Exercise Capacity, Muscle Oxygenation and Physical Activity Level in Parkinson's Patients

Study Type:

OBSERVATIONAL

Last Updated:

2026-08-04

Start Date:

2023-04-01

Completion:

2024-05-20

Conditions

• Parkinson Disease

No Results Yet

NCT05739981 | RECRUITING | PHASE1/PHASE2

30 participants

Phase II IMNN-001 (Also Known as GEN-1) on SLL With BEV and NACT, Newly Diagnosed Advanced Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-04

Start Date:

2023-02-10

Completion:

2027-06-30

Conditions

• Ovarian Cancer
• Fallopian Tube Cancer
• Primary Peritoneal Cancer

Interventions

• DRUG

No Results Yet

NCT05677100 | RECRUITING | NA

320 participants

Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-04

Start Date:

2023-08-23

Completion:

2028-01-31

Conditions

• Heart Failure
• Cardiorenal Syndrome
• Cardio-Renal Syndrome
• ADHF
• Heart Failure, Systolic
• Heart Failure, Diastolic
• Heart Failure; With Decompensation
• Heart Failure, Congestive

Interventions

• DEVICE

No Results Yet

NCT05663515 | RECRUITING

24000 participants

A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs

Study Type:

OBSERVATIONAL

Last Updated:

2026-08-04

Start Date:

2024-09-30

Completion:

2026-10-01

Conditions

• Pancreatic Cancer

Interventions

• DRUG

No Results Yet

NCT05621564 | RECRUITING

6032 participants

Pre-operative Therapy in Breast Cancer

Study Type:

OBSERVATIONAL

Last Updated:

2026-08-04

Start Date:

2022-11-01

Completion:

2030-11-30

Conditions

• Breast Cancer

Interventions

• DRUG

No Results Yet

NCT05619991 | COMPLETED | NA

90 participants

Effect of Short Film Video and Video-Based Education on Fear, Pain, and Satisfaction of Children Undergoing Day Surgery

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-04

Start Date:

2022-12-01

Completion:

2023-10-25

Conditions

• Day Surgery
• Fear
• Pain
• Satisfaction
• CHİLDREN

Interventions

• OTHER

No Results Yet

NCT05619627 | NOT_YET_RECRUITING | PHASE1

18 participants

Oral Dexmedetomidine in Pediatric MRI

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-04

Start Date:

2026-11-01

Completion:

2027-11-30

Conditions

• Anesthesia

Interventions

• DRUG

No Results Yet

NCT05618379 | ACTIVE_NOT_RECRUITING

200 participants

Adult Spinal Muscular Atrophy (SMA) China Registry

Study Type:

OBSERVATIONAL

Last Updated:

2026-08-04

Start Date:

2023-01-06

Completion:

2028-06-01

Conditions

• Muscular Atrophy, Spinal

No Results Yet

NCT05609916 | RECRUITING | NA

200 participants

CBT Augmentation to Promote Medication Discontinuation in Pediatric OCD

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-04

Start Date:

2022-11-30

Completion:

2027-07-30

Conditions

• Cognitive Behavioral Therapy
• Obsessive-Compulsive Disorder
• Obsessive-Compulsive Disorder in Children
• Obsessive-Compulsive Disorder in Adolescence

Interventions

• BEHAVIORAL

No Results Yet

NCT05586243 | RECRUITING

5 participants

MAGNETIC RESONANCE SPECTROSCOPY BIOMARKERS IN TYPE 3 GAUCHER DISEASE (GD3)

Study Type:

OBSERVATIONAL

Last Updated:

2026-08-04

Start Date:

2023-01-01

Completion:

2026-12-31

Conditions

• Gaucher Disease, Type 3

Interventions

• OTHER

No Results Yet

NCT05579366 | RECRUITING | PHASE1/PHASE2

884 participants

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-04

Start Date:

2022-12-07

Completion:

2027-07-31

Conditions

• High Grade Epithelial Ovarian Cancer
• High Grade Serous Ovarian Cancer
• Primary Peritoneal Carcinoma
• Fallopian Tube Cancer
• Endometrial Cancer
• Non-small Cell Lung Cancer
• Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer (NSCLC)
• Mesothelioma
• Breast Adenocarcinoma
• Triple Negative Breast Cancer
• Hormone Receptor-positive/Her2 Negative Breast Cancer
• Platinum-resistant Ovarian Cancer (PROC)
• Platinum Sensitive Ovarian Cancer (PSOC)
• Primary Refractory Ovarian Cancer
• Uterine Cancer

Interventions

• DRUG

No Results Yet

NCT05567198 | RECRUITING

100 participants

Gonadotropin-releasing Hormone Agonist (GnRHa) in Ovarian Preservation in SLE Subjects Receiving Cyclophosphamide as Determined by Questionnaires

Study Type:

OBSERVATIONAL

Last Updated:

2026-08-04

Start Date:

2023-03-03

Completion:

2027-05-31

Conditions

• Systemic Lupus Erythematosus (Sle)
• Primary Ovarian Insufficiency (Poi)

No Results Yet

NCT05564403 | ACTIVE_NOT_RECRUITING | PHASE2

66 participants

Study of Chemotherapy, With or Without Binimetinib in Advanced Biliary Tract Cancers in 2nd Line Setting (A ComboMATCH Treatment Trial)

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-04

Start Date:

2024-02-09

Completion:

2026-10-01

Conditions

• Advanced Biliary Tract Carcinoma
• Advanced Gallbladder Carcinoma
• Advanced Intrahepatic Cholangiocarcinoma
• Recurrent Biliary Tract Carcinoma
• Recurrent Gallbladder Carcinoma
• Recurrent Intrahepatic Cholangiocarcinoma
• Stage III Distal Bile Duct Cancer AJCC v8
• Stage III Gallbladder Cancer AJCC v8
• Stage III Hilar Cholangiocarcinoma AJCC v8
• Stage III Intrahepatic Cholangiocarcinoma AJCC v8
• Stage IV Distal Bile Duct Cancer AJCC v8
• Stage IV Gallbladder Cancer AJCC v8
• Stage IV Hilar Cholangiocarcinoma AJCC v8
• Stage IV Intrahepatic Cholangiocarcinoma AJCC v8
• Unresectable Biliary Tract Carcinoma
• Unresectable Gallbladder Carcinoma
• Unresectable Intrahepatic Cholangiocarcinoma

Interventions

• DRUG
• PROCEDURE

No Results Yet

NCT05562947 | RECRUITING | PHASE3

68 participants

A Study of the Efficacy, Safety, and Pharmacokinetics (PK) of the Port Delivery System With Ranibizumab (PDS) in Chinese Participants With Neovascular Age-related Macular Degeneration (nAMD)

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-04

Start Date:

2024-06-17

Completion:

2027-07-27

Conditions

• Neovascular Age-related Macular Degeneration
• nAMD

Interventions

• DEVICE
• DRUG

No Results Yet

NCT05554367 | ACTIVE_NOT_RECRUITING | PHASE2

199 participants

Palbociclib and Binimetinib in RAS-Mutant Cancers, A ComboMATCH Treatment Trial

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-04

Start Date:

2023-12-13

Completion:

2026-08-26

Conditions

• Exocrine Pancreas Carcinoma
• Malignant Solid Neoplasm
• Ovarian Low Grade Serous Adenocarcinoma
• Stage IV Ovarian Cancer AJCC v8
• Stage IV Pancreatic Cancer AJCC v8

Interventions

• DRUG
• PROCEDURE

No Results Yet

NCT05554341 | ACTIVE_NOT_RECRUITING | PHASE2

40 participants

Testing the Use of Nilotinib and Paclitaxel as a Treatment for Patients With Prior Taxane Treatment, A ComboMATCH Treatment Trial

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-04

Start Date:

2023-07-14

Completion:

2027-06-30

Conditions

• Metastatic Malignant Solid Neoplasm
• Refractory Malignant Solid Neoplasm

Interventions

• PROCEDURE
• DRUG

No Results Yet

NCT05554328 | ACTIVE_NOT_RECRUITING | PHASE2

165 participants

Testing the Use of the Combination of Selumetinib and Olaparib or Selumetinib Alone Targeted Treatment for RAS Pathway Mutant Recurrent or Persistent Ovarian and Endometrial Cancers, A ComboMATCH Treatment Trial

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-04

Start Date:

2023-04-25

Completion:

2028-10-01

Conditions

• Recurrent Endometrial Carcinoma
• Recurrent Fallopian Tube Carcinoma
• Recurrent Ovarian Carcinoma
• Recurrent Primary Peritoneal Carcinoma

Interventions

• PROCEDURE
• DRUG

No Results Yet

NCT05471856 | RECRUITING | PHASE1

66 participants

A Study to Test How Different Doses of BI 1703880 in Combination With Ezabenlimab Are Tolerated in People With Different Types of Advanced Cancer (Solid Tumours)

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-04

Start Date:

2023-02-24

Completion:

2028-09-13

Conditions

• Solid Tumors

Interventions

• DRUG

No Results Yet